3-[[2-(dimethylamino)-2-thiophen-2-ylethyl]iminomethyl]-4-hydroxychromen-2-one
C18H18N2O3S — CID 135638212
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[[2-(dimethylamino)-2-thiophen-2-ylethyl]iminomethyl]-4-hydroxychromen-2-one
3-[[2-(dimethylamino)-2-thiophen-2-ylethyl]iminomethyl]-4-hydroxychromen-2-one (PubChem CID 135638212) has the molecular formula C18H18N2O3S and a molecular weight of 342.42 g/mol. Its IUPAC name is 3-[[2-(dimethylamino)-2-thiophen-2-ylethyl]iminomethyl]-4-hydroxychromen-2-one.
Molecular Properties
| Compound Name | 3-[[2-(dimethylamino)-2-thiophen-2-ylethyl]iminomethyl]-4-hydroxychromen-2-one |
|---|---|
| PubChem CID | 135638212 |
| Molecular Formula | C18H18N2O3S |
| Molecular Weight | 342.42 g/mol |
| Exact Mass | 342.10 |
| IUPAC Name | 3-[[2-(dimethylamino)-2-thiophen-2-ylethyl]iminomethyl]-4-hydroxychromen-2-one |
| SMILES | CN(C)C(C/N=C/c1c(O)c2ccccc2oc1=O)c1cccs1 |
| InChI | InChI=1S/C18H18N2O3S/c1-20(2)14(16-8-5-9-24-16)11-19-10-13-17(21)12-6-3-4-7-15(12)23-18(13)22/h3-10,14,21H,11H2,1-2H3/b19-10+ |
| InChIKey | WOSAAEADDLGXKY-VXLYETTFSA-N |
| XLogP | 3.28 |
| TPSA | 66.04 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 342.42 |
| LogP ≤ 5 | 3.28 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'cumarine', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135638212 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.